v3.26.1
Summary of Significant Accounting Policies (Tables)
9 Months Ended
Mar. 31, 2026
Accounting Policies [Abstract]  
Schedule of Accounts Receivable

The following is a summary of the Company’s accounts receivable at March 31, 2026 and June 30, 2025:

 

   March 31, 2026   June 30, 2025 
         
Accounts receivable  $314,310   $98,177 
Less: allowance for credit losses   54,498    51,962 
Accounts receivable - net  $259,812   $46,215 
Schedule of Bad Debt

For the three and nine months ended March 31, 2026 and 2025, bad debt was as follows:

 

Three Months Ended March 31, 
2026   2025 
$(7,408)  $- 

 

Nine Months Ended March 31, 
2026   2025 
$58,769   $- 
Schedule of Inventory

At March 31, 2026 and June 30, 2025, inventory was as follows:

 

Classification  March 31, 2026   June 30, 2025 
Packaging and supplies  $343,810   $319,491 
Food and beverage   41,349    - 
Total Inventory  $385,159   $319,491 
Schedule of Disaggregation of Revenue

The following represents the Company’s disaggregation of revenues for the nine months ended March 31, 2026 and 2025:

 

   Nine Months Ended March 31, 
   2026   2025 
                 
   Revenue   % of Revenues   Revenue   % of Revenues 
Foodservice Packaging  $1,091,895    19.22%  $-    0.00%
Robotics as a Service (RaaS)   37,986    0.67%   1,681    100.00%
Hotels   4,551,198    80.11%   -    0.00%
Total revenues - net  $5,681,079    100.00%  $1,681    100.00%
Schedule of Marketing and Advertising Costs

The Company recognized marketing and advertising costs during the three and nine months ended March 31, 2026 and 2025, respectively as follows:

 

   2026   2025 
   Three Months Ended March 31, 
   2026   2025 
           
Total Sales and Marketing  $49,564   $6,466 

 

   2026   2025 
   Nine Months Ended March 31, 
   2026   2025 
           
Total Sales and Marketing  $139,616   $10,442 
Schedule of Dilutive Equity Securities Outstanding

The following potentially dilutive securities were excluded from the computation of diluted net loss per share for the nine months ended March 31, 2026 and 2025 because their effect would have been anti-dilutive:

 

   March 31, 2026   March 31, 2025 
Convertible debt   137,111,874    347,064,656 
Series B, convertible preferred stock (8,366:1)   -    9,750,000 
Series C, convertible preferred stock (6,000:1)   13,578,000    798,498,000 
Series D, convertible preferred stock (6,000:1)   11,004,000    20,004,000 
Warrants   193,651,646    191,996,343 
Total common stock equivalents   355,345,520    1,367,312,999